Berman Tabacco

Norvir Antitrust

In re Abbott Laboratories Norvir Antitrust Litigation, Nos. 04-1511, 04-4203 (N.D. Cal.)

Berman Tabacco acted as co-lead counsel in a case on behalf of indirect purchasers alleging that the defendant pharmaceutical company engaged in an illegal leveraged monopoly in the sale of its AIDS boosting drug known as Norvir (or Ritanovir). The case settled for $10 million, which was distributed net of fees and costs on a cy pres basis to 10 different AIDS research and charity organizations throughout the United States.

Case Information

  • Settlement Amount:
    $10,000,000